Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively

CD4+CD25−Foxp3− Th1 cells are the source of IL-10–mediated immune suppression in chronic cutaneous leishmaniasis

Charles Anderson, Mohammed Oukka, Vijay J. Kuchroo et al. · The Journal of Experimental Medicine · 2007 · 563 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +25

Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains of<i>Leishmania donovani</i>

Rosalía Lira, Shyam Sundar, Anand Makharia et al. · The Journal of Infectious Diseases · 1999 · 359 citations · Full text

rK39: A Cloned Antigen of Leishmania chagasi that Predicts Active Visceral Leishmaniasis

Roberto Badaró, Darin R. Benson, Maria Eulalio et al. · The Journal of Infectious Diseases · 1996 · 294 citations · Full text

Rk39 Seroreactivity, Active Visceral Leishmaniasis, Parasitic Disease +13

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran

Iraj Sharifi, Alireza Fekri, Mohammad-Reza Aflatonian et al. · The Lancet · 1998 · 237 citations

Vaccination, Parasitic Protozoa, Anthroponotic Cutaneous Leishmaniasis +6

Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan

A. M. A. El Hassan, EE Zijlstra, MM Mukhtar et al. · The Lancet · 2000 · 232 citations

Vaccination, Vaccine Development, Vaccine Target +6